ReShape Lifesciences Inc. (RSLS)
NASDAQ: RSLS
· Real-Time Price · USD
3.92
0.72 (22.50%)
At close: Aug 14, 2025, 3:59 PM
ReShape Lifesciences Revenue
ReShape Lifesciences reported an annual revenue of $8.01M, reflecting a -7.74% growth. For the quarter ending March 31, 2025, ReShape Lifesciences generated $1.11M in revenue.
Revenue (ttm)
8.01M
Revenue Growth
-7.74%
Price / Sales Ratio
7.18
Revenue / Employee
470.94K
Employees
17
Market Cap
9.35M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | % Change |
---|